Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec in NF1 Patients With Plexiform Neurofibromas
NCT01673009Phase 2Completed
- Sponsor
- Indiana University
- Start
- May 2006
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in neurofibromatosis type 1 (NF1), sponsored by Indiana University. Primary endpoint: Percent Change From Baseline in Tumor Volume at 6 Months. Started May 2006; status: completed.
02
Drugs
03
Conditions
neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on NCT01673009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01673009.